The MarketReader Minute
💊 Biotech Stocks Surge as Nuvalent Leads with Breakthrough Cancer Data, While Summit Slips Amid Insider Trading | Biotech Sector Insights
Ascendis Pharma A/S (ASND) experienced a notable stock increase following positive results from the ApproaCH Trial, which demonstrated superior growth velocity in children with achondroplasia.